Nutra Pharma Corp. Stock Price - NPHC

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$44.59
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
SMALL CAP BASIC
Monthly Subscription
for only
$30.03
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Nutra Pharma Corp. (PC) NPHC Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 0.0017 0.0019 0.0017 0.0018 0.0017 09:35:54
Bid Price Ask Price Spread Spread % News
0.0017 0.0018 0.0001 5.56% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
11 6,943,368 $ 0.0019 $ 12.96k 32.91M 0.0004 - 0.0100
Last Trade Time Type Quantity Stock Price Currency
09:35:55 500,000 $0.00 USD

Nutra Pharma Corp. (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.17M 1.86B $ -3.45M - -0.92 1.47B
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Nutra Pharma Corp. (PC) News

Latest NPHC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NPHC Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.000750.0020.000750.001533M61M48M0.00095126.67%
1 Month0.00050.0020.00050.00106M96M30M0.0012240.00%
3 Months0.00040.0020.00040.0008817k225M30M0.0013325.00%
6 Months0.00160.00220.00040.0010817k291M48M0.00016.25%
1 Year0.00830.010.00040.001336k691M37M-0.0066-79.52%
3 Years0.00690.270.00040.00190691M13M-0.0052-75.36%
5 Years0.0090.270.00040.00300691M9M-0.0073-81.11%

Nutra Pharma Corp. (PC) Description

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin and Pet Pain-Away.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.